Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Committee Votes topic
No spam. Unsubscribe anytime.
Senate Health committee advances broad package of health bills, sends multiple substitutes to fiscal and rules committees
Summary
After public hearings, the committee moved into executive session and gave due‑pass recommendations or adopted proposed substitutes for a batch of health bills including SB 5899 (chiropractic endorsement), SB 6292 (joint legislative executive committee on healthcare financing), SB 6094 (pediatric transitional care payments and grants), SB 5947 (Washington Healthcare Board), SB 5933 (overdose mapping), SB 5823 (patient advocates), SB 6210 (health plan certification), SB 5921 (psilocybin), SB 6226 (audiologist clinical autonomy) and SB 5924 (pharmacists' prescriptive authority).
Following the public hearings on gubernatorial appointments, the Senate Health and Long Term Care Committee moved into executive session and advanced a large set of health bills on Feb. 3, taking voice votes to adopt proposed substitutes where applicable and to recommend due passage or referral to fiscal committees.
Key actions taken included a due‑pass recommendation for SB 5899 (license endorsement allowing qualified licensed chiropractors to perform certain diagnostic and adjustment services on non‑human animals); adoption and recommendation of a substitute for SB 6292 (creating a joint legislative‑executive committee on healthcare financing; proposed substitute S‑4612.1); adoption of the proposed substitute for SB 6094 (directing a feasibility and cost study and interim grant funds related to pediatric transitional care; S‑4627.1, report due Nov. 1, 2026); and passage of SB 5947 (establishing the Washington Healthcare Board).
The committee also advanced SB 5933 (overdose mapping information sharing; proposed substitute S‑455.1) and a package of Group 2 bills after staff briefings: SB 5823 (patient advocates; proposed substitute S‑4526.2), SB 6210 (health plan certification; proposed substitute S‑4537.1), SB 5921 (psilocybin), SB 6226 (audiologist clinical autonomy; S‑4630.1), and SB 5924 (expanded prescriptive authority for pharmacists; proposed substitute S‑4435.1). Several of these actions were adopted and recommended to the Rules Committee or Ways & Means as appropriate.
Many votes were taken by voice and recorded as passed or adopted subject to signatures; individual recorded roll‑call tallies were not provided in the committee transcript. The committee concluded its agenda and adjourned after completing executive session votes.
Votes at a glance (committee action summary): - SB 5899 — Due pass recommendation (sent to Rules) - SB 6292 (S‑4612.1) — Proposed substitute adopted and recommended (sent to Rules) - SB 6094 (S‑4627.1) — Proposed substitute adopted and recommended (sent to Ways & Means) - SB 6182 (S‑4532.1, amended) — Amended substitute adopted and sent to Ways & Means - SB 5947 — Due pass recommendation (sent to Rules) - SJR 8206 — Due pass recommendation (sent to Ways & Means) - SB 5933 (S‑455.1) — Proposed substitute adopted and recommended (sent to Ways & Means) - SB 5823 (S‑4526.2) — Proposed substitute adopted and recommended (sent to Ways & Means) - SB 6210 (S‑4537.1) — Proposed substitute adopted and recommended (sent to Rules) - SB 5921 — Due pass recommendation (sent to Ways & Means) - SB 6226 (S‑4630.1) — Proposed substitute adopted and recommended (sent to Rules) - SB 5924 (S‑4435.1) — Proposed substitute adopted and recommended (sent to Rules)
What’s next: Most bills were reported with recommendations and will move to the next committee(s) named by the committee (Rules, Ways & Means) for fiscal review or procedural scheduling.
